Pembrolizumab-Induced Myasthenia Gravis and Myositis: Literature Review on Neurological Toxicities of Programmed Death Protein 1 Inhibitors

We present herein the case of an elderly male patient, who was receiving immunotherapy for his urothelial cancer and who presented to our facility with lower extremity weakness. The patient was diagnosed with myasthenia gravis, thyroiditis, myositis and myocarditis, which were considered as immune a...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwab, Alfred, Assaad, Marc, Hamadi, Rachelle, Zurndorfer, Juda, Abi Melhem, Racha, Holtzbach, Jennifer, Loeffler, Jeffrey, Ibrahim, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728146/
https://www.ncbi.nlm.nih.gov/pubmed/36506763
http://dx.doi.org/10.14740/jmc4008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728146/
https://www.ncbi.nlm.nih.gov/pubmed/36506763
http://dx.doi.org/10.14740/jmc4008

Ejemplares similares